Biochemical Engineering

Novavax delays COVID-19 vaccine regulatory submissions

Novavax delays COVID-19 vaccine regulatory submissions

11th May 2021

Novavax will not file for approval of its COVID-19 vaccine until July at the earliest, thanks to manufacturing issues related to an assay needed to show regulators that its vaccine manufacturing process is consistent across different sites. Besides delays with the assay, the company has also run into shortages of raw materials, such as 2,000-liter plastic bags used to grow cells for vaccine production. This has cut the company’s expected production numbers by about half. Source: Fierce Biotech 11/5/2021


Back to group news